Introduction
Patents are among the most powerful and commercially significant forms of intellectual property protection available to US businesses. A patent confers on its owner the exclusive right to prevent others from making, using, selling, offering for sale, or importing the patented invention within the United States for a defined period of time. In exchange for that exclusivity, the patent owner must fully disclose the invention to the public — a bargain struck between the inventor and society that lies at the heart of the US patent system. The underlying policy rationale is that the temporary monopoly granted by a patent incentivizes innovation and investment in research and development, while the mandatory public disclosure advances the state of knowledge and eventually enriches the public domain.
For businesses, patents serve multiple strategic functions. A well-constructed patent portfolio can exclude competitors from key markets, create barriers to entry in technology-intensive industries, generate licensing revenue, increase the valuation of a company in financing and acquisition transactions, and serve as a deterrent against infringement claims by competitors. Conversely, operating in an industry without understanding the patent landscape exposes a business to infringement claims that can be enormously costly to defend and that may result in injunctions, damages awards, or forced design-arounds that disrupt core products and services.
This article provides a comprehensive overview of US patent law for business audiences. It covers the types of patents available, the fundamental requirements for patentability, the process of obtaining a patent through the United States Patent and Trademark Office (USPTO), the scope and limits of patent rights, strategies for building and managing a patent portfolio, enforcement of patent rights, and key developments in patent law that businesses operating in technology-intensive sectors should understand.
Constitutional and Statutory Foundation
The US patent system traces its authority directly to the Constitution. Article I, Section 8, Clause 8 grants Congress the power “to promote the Progress of Science and useful Arts, by securing for limited Times to Authors and Inventors the exclusive Right to their respective Writings and Discoveries.” Congress first exercised this authority with the Patent Act of 1790, and the current statutory framework is the Patent Act of 1952, codified at Title 35 of the United States Code, as substantially amended by the Leahy-Smith America Invents Act (AIA) of 2011, which represented the most comprehensive reform of US patent law in more than sixty years.
The AIA made two changes of particular importance to businesses. First, it converted the United States from a first-to-invent system — in which the patent was awarded to the party who could prove they invented first, even if they were not the first to file — to a first-inventor-to-file system, in which priority is generally determined by the date of the patent application. This change aligned US law more closely with the practice of virtually every other major patent jurisdiction in the world and substantially increased the urgency of filing patent applications promptly. Second, the AIA created the Patent Trial and Appeal Board (PTAB), an administrative tribunal within the USPTO that hears post-grant challenges to the validity of issued patents — a development that has significantly affected patent enforcement strategy, as discussed further below.
Types of Patents
Utility Patents
Utility patents are by far the most common and commercially significant type of patent. They protect any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof. The vast majority of patents granted by the USPTO are utility patents, covering innovations ranging from pharmaceutical compounds and industrial processes to software algorithms and business methods. A utility patent provides protection for twenty years from the filing date of the earliest related application, subject to the payment of maintenance fees at prescribed intervals. Without timely payment of maintenance fees, a utility patent lapses and the invention enters the public domain.
Design Patents
Design patents protect the ornamental or aesthetic appearance of a functional article — the way a product looks, rather than the way it works. If a utility patent is a protection for function, a design patent is a protection for form. Design patents have a term of fifteen years from the date of grant (for applications filed after May 13, 2015) and require no maintenance fees. They have grown in commercial importance, particularly in consumer electronics, automotive design, and consumer products industries. The Apple v. Samsung litigation, in which Apple obtained substantial design patent damages based on the overall appearance of smartphone elements, highlighted the potential commercial value of design patent portfolios and prompted a reassessment of design patent strategy by technology companies across the industry.
Plant Patents
Plant patents protect new and distinct varieties of asexually reproduced plants — that is, plants reproduced by means other than seeds, such as by grafting, budding, or cuttings. Plant patents are relevant primarily to agricultural businesses, horticultural companies, and plant breeders. Separately, sexually reproduced plant varieties may be protected under the Plant Variety Protection Act, administered by the US Department of Agriculture rather than the USPTO. The plant patent area is a highly specialized field and is not addressed in detail in this overview, but businesses in agribusiness and related industries should be aware of the protections available.
Provisional Patent Applications
Although not a type of granted patent, provisional patent applications deserve mention because they are widely used and often misunderstood by businesses. A provisional application establishes an early filing date and gives the applicant twelve months to file a corresponding non-provisional application that claims priority to the provisional. During that twelve-month period, the applicant may use the designation “Patent Pending,” which provides notice to the marketplace. Provisionals are relatively inexpensive to prepare, do not require formal claims, and are never examined. They can be a valuable tool for securing an early filing date while a product is still being refined and a business is deciding whether to invest in the full prosecution process. However, the provisional must describe the invention with sufficient detail to support the claims that will ultimately be pursued in the non-provisional application, and a poorly prepared provisional that fails to adequately disclose the invention provides little practical benefit.
Requirements for Patentability
To obtain a utility patent, an invention must satisfy four fundamental requirements: it must constitute patentable subject matter, it must be novel, it must be non-obvious, and it must be adequately disclosed in the patent application. Each of these requirements warrants careful examination.
Patentable Subject Matter
Section 101 of the Patent Act provides that any new and useful process, machine, manufacture, or composition of matter is eligible for patent protection. These categories are intended to be broad. However, the Supreme Court has identified three categories of subject matter that are not patent-eligible regardless of how the claims are drafted: laws of nature, natural phenomena, and abstract ideas. These exclusions reflect the principle that the basic building blocks of science and human thought cannot be monopolized by any single party.
The application of these exclusions to modern technology — particularly software, business methods, and biotechnology — has been among the most contested and commercially consequential areas of patent law over the past two decades. The Supreme Court’s decisions in Mayo Collaborative Services v. Prometheus Laboratories (2012) and Alice Corporation v. CLS Bank International (2014) established a two-step framework for analyzing patent eligibility. Under Alice/Mayo, a court first asks whether the claims at issue are directed to a patent-ineligible concept (a law of nature, natural phenomenon, or abstract idea). If so, the court asks whether the claims contain an “inventive concept” — some element or combination of elements that is sufficient to ensure that the patent amounts to significantly more than a claim on the ineligible concept itself.
The Alice/Mayo framework has been applied aggressively by courts and the USPTO to invalidate a wide range of software and business method patents that were found to do no more than implement an abstract idea on a generic computer. For technology companies, software developers, and financial services firms, this body of law creates real uncertainty about the patent-eligibility of software-implemented inventions. Careful claim drafting that emphasizes specific technical improvements, concrete technical implementations, and improvements to computer functionality — rather than abstract business or mathematical methods — is essential for surviving Section 101 scrutiny. This is an area where the involvement of experienced patent counsel from the earliest stages of the patent application process is particularly critical.
Novelty
An invention is novel if it has not been previously disclosed in a way that would constitute prior art under the Patent Act. Under the AIA’s first-inventor-to-file system (35 U.S.C. § 102), an invention lacks novelty if it was patented, described in a printed publication, in public use, on sale, or otherwise available to the public before the effective filing date of the patent application. The AIA also provides a one-year grace period that protects an inventor’s own public disclosures made within twelve months of the filing date, meaning that an inventor who publicly discloses their invention does not immediately forfeit patent rights in the United States, provided they file within one year of the disclosure.
This grace period is unique to US law. In most foreign jurisdictions, any public disclosure before the filing date destroys novelty without exception. Businesses that have US patent applications in mind but also intend to seek patent protection internationally must be acutely aware of this difference: a public disclosure that is harmless to US rights under the grace period may irrevocably destroy the ability to obtain patent protection in the European Union, China, Japan, and other major markets. Filing a patent application — or at minimum a provisional application — before making any public disclosure is the only reliable way to preserve both US and international patent rights.
Non-Obviousness
Even a novel invention may not be patentable if it would have been obvious to a person of ordinary skill in the relevant field at the time the invention was made. The non-obviousness requirement, codified at 35 U.S.C. § 103, prevents the patent system from granting monopolies over incremental variations and minor improvements that skilled practitioners would naturally arrive at without inventive effort.
The legal standard for non-obviousness was established by the Supreme Court in Graham v. John Deere Co. (1966) and refined in KSR International Co. v. Teleflex Inc. (2007). The analysis requires determining the scope and content of the prior art, the differences between the prior art and the claimed invention, the level of ordinary skill in the field, and any secondary considerations — also called objective indicia of non-obviousness — such as long-felt but unsolved need for the invention, failure of others to achieve the solution, commercial success attributable to the claimed features, and copying of the invention by competitors. These secondary considerations can be powerful evidence of non-obviousness in close cases and should be documented by businesses from the earliest stages of product development.
Adequate Disclosure: Written Description, Enablement, and Definiteness
A patent application must adequately disclose the invention in return for the exclusive rights it seeks. The specification must contain a written description of the invention sufficient to demonstrate that the inventor actually possessed the invention at the time of filing — a requirement that prevents inventors from claiming more than they have actually invented. The specification must also enable a person of ordinary skill in the field to make and use the invention without undue experimentation. And the claims — the numbered paragraphs at the end of a patent that define the legal scope of the patent owner’s rights — must be sufficiently definite that skilled practitioners can determine whether a given product or process falls within the patent’s scope. Failure to meet any of these disclosure requirements can render a patent invalid.
The Patent Application Process
Preparing and Filing the Application
A patent application consists of a specification (including a detailed description of the invention and, typically, drawings), an abstract, and claims. The claims are the most legally critical part of the application because they define the boundaries of the patent monopoly. Drafting claims that are both broad enough to provide meaningful commercial protection and specific enough to distinguish the invention from prior art is a skill that lies at the heart of patent prosecution and that requires experienced patent counsel.
Applications are filed with the USPTO either as provisional applications (to establish an early filing date, as described above) or as non-provisional applications that enter the formal examination process. Non-provisional applications are assigned to a patent examiner with relevant technical expertise who will examine the application for compliance with all patentability requirements. Applicants have a duty of candor to the USPTO and must disclose all known prior art that may be material to the examination. Failure to comply with this duty of candor can render the resulting patent unenforceable through a doctrine known as inequitable conduct.
Prosecution: Examination and Office Actions
Patent prosecution — the back-and-forth process between the applicant and the examiner — typically begins when the examiner issues an Office Action rejecting some or all of the claims on various grounds. The applicant then has the opportunity to respond, either by arguing against the rejections, by amending the claims to overcome prior art, or both. This iterative process may go through multiple rounds before the examiner either allows the application or issues a final rejection. The average pendency of a US patent application from filing to issuance is currently around two to three years, though it varies significantly by technology area. Prosecution can be more rapid in some fields and significantly longer in others.
Importantly, the arguments made and claim amendments submitted during prosecution become part of the public record and can affect the scope of the patent’s protection through a doctrine called prosecution history estoppel. A patent owner who narrows claims or makes limiting arguments to overcome prior art during prosecution may later be estopped from asserting that the narrowed claims cover subject matter equivalent to what was surrendered. Understanding and managing prosecution history is an important aspect of patent strategy.
Patent Costs
The cost of obtaining a US utility patent varies considerably depending on the complexity of the invention, the number of claims, the number of rounds of prosecution required, and the fees charged by outside counsel. As a general benchmark, businesses should expect total costs from initial application through issuance to range from approximately $10,000 to $30,000 or more for a moderately complex invention, with additional costs for maintenance fees over the life of the patent (currently $1,600, $3,600, and $7,400 at 3.5, 7.5, and 11.5 years from grant, respectively, for large entities, with reduced fees for small and micro entities). For businesses with global aspirations, international filing costs can be substantially higher, particularly if protection is sought in multiple jurisdictions through the PCT process described below.
International Patent Protection
A US patent provides protection only within the United States. Businesses that operate internationally or that face foreign competition must obtain separate patent protection in each country where they seek exclusivity. The Patent Cooperation Treaty (PCT), administered by the World Intellectual Property Organization (WIPO), provides a streamlined mechanism for filing a single international application that preserves the right to pursue national phase applications in over 150 member countries within thirty months of the earliest priority date. The PCT process does not result in an “international patent”; it merely delays and consolidates the initial filing steps, after which applicants must prosecute separate national applications in each country of interest. Strategic decisions about which countries to pursue should be made early and informed by a realistic assessment of where the business’s key markets and competitors are located.
The Scope and Limits of Patent Rights
What a Patent Grants
A common misconception is that a patent grants its owner the right to practice the invention. In fact, a patent grants only the right to exclude others from making, using, selling, offering for sale, or importing the claimed invention in the United States. This distinction matters: a patent owner may itself be unable to practice its own patented invention if doing so would infringe someone else’s earlier, broader patent. This situation — known as blocking patents — is common in technology-intensive industries where complex products incorporate hundreds or thousands of patented technologies owned by different parties.
The scope of the exclusive right is defined by the claims, interpreted in light of the specification, the prosecution history, and relevant extrinsic evidence. Courts use a process called claim construction to determine the meaning and scope of claim terms — a determination that is often the central dispute in patent infringement litigation. A patentee’s rights extend not only to products and processes that literally fall within every element of a claim but also to equivalents — products or processes that perform substantially the same function in substantially the same way to achieve substantially the same result — under the doctrine of equivalents, though this doctrine has been considerably narrowed by the courts over the past few decades.
Limitations on Patent Rights
Patent rights are subject to several important limitations. The doctrine of patent exhaustion (also called the first sale doctrine) provides that once a patented article is sold by the patent owner or with the patent owner’s authorization, the patent owner’s rights in that particular article are exhausted and cannot be asserted against downstream purchasers and users. This principle was reaffirmed and significantly expanded by the Supreme Court in Impression Products, Inc. v. Lexmark International, Inc. (2017), which held that patent exhaustion applies even to authorized sales made outside the United States. The exhaustion doctrine has important implications for businesses that manufacture or distribute patented goods and for businesses that purchase and resell goods that may incorporate patented technology.
Patent rights also do not preclude research activities in certain limited circumstances. The experimental use exception — a judicially created doctrine of very narrow scope in the United States — permits purely philosophical or academic research on a patented invention. In practical terms, however, this exception is so narrow that commercial entities conducting research and development using patented technology cannot generally rely on it. A separate, statutory safe harbor under 35 U.S.C. § 271(e)(1) permits activities — including the manufacture and use of a patented invention — that are reasonably related to generating information for submission to the FDA or other regulatory agencies. This provision is particularly important for pharmaceutical and medical device companies that need to conduct studies on patented drugs or devices to support regulatory approval applications.
Building and Managing a Patent Portfolio
Developing an IP Strategy
Obtaining individual patents is relatively straightforward; building a patent portfolio that provides coherent, durable, and commercially meaningful protection for a business’s innovations requires deliberate strategy. An effective patent strategy begins with a clear understanding of the business’s competitive landscape, the technology areas in which it operates, and the specific features of its products and services that are most important to protect. Not every innovation warrants a patent application — some inventions are better protected as trade secrets (which have no expiration date, unlike patents, but require active secrecy measures), and the costs of building a broad patent portfolio must be weighed against the commercial benefits.
A patent portfolio strategy should consider breadth as well as depth. Broad pioneering patents that cover the core concept of a technology may be the most valuable, but they are also the most likely to face validity challenges. A portfolio that combines broad claims with narrower dependent claims covering specific implementations provides layered protection: even if the broadest claims are invalidated, narrower claims may survive and still provide meaningful exclusivity. This layered approach — sometimes described as building a “patent thicket” around a technology — is standard practice in pharmaceutical, semiconductor, and software industries.
Freedom to Operate Analysis
Before launching a new product or entering a new market, businesses should conduct a freedom-to-operate (FTO) analysis — a systematic review of third-party patents that may cover the proposed product or process. An FTO analysis identifies patents that pose infringement risk, assesses the strength and scope of those patents, and informs decisions about whether to design around blocking patents, seek licenses, or challenge the validity of problematic patents. FTO analysis is particularly important before investing heavily in a new product line, before entering into a manufacturing agreement, or before a financing or acquisition transaction in which IP-related liabilities are being assessed by investors or acquirers.
An FTO analysis cannot guarantee that a product is free of infringement risk — not all patents are easily discovered, and claim construction is often uncertain — but it demonstrates due diligence and can significantly mitigate liability if infringement is later alleged. A defendant who has obtained and relied upon a competent FTO opinion, provided by qualified patent counsel, is generally not found to have willfully infringed, which matters significantly because willful infringement can result in enhanced damages of up to three times the actual damages award under 35 U.S.C. § 284.
Employee Invention Assignment Agreements
Businesses must ensure that they actually own the patents they seek to enforce. Under US law, an invention is initially owned by the human inventor, not by the employer, even if the invention was created during working hours using company resources. Ownership of employee inventions is transferred to the employer only if the employee has entered into a written invention assignment agreement (also called an assignment of inventions or IP assignment agreement). Every business should require all employees and contractors who may conceive of patentable inventions to sign such an agreement as a condition of employment or engagement. Failure to do so can result in the company lacking ownership of its most commercially significant innovations — a defect that can be devastating in litigation or in a business transaction where clean title to intellectual property is required.
Patent Infringement and Enforcement
Types of Infringement
Direct infringement occurs when a party makes, uses, sells, offers for sale, or imports a patented invention in the United States without authorization. Indirect infringement takes two forms: induced infringement, where a party actively encourages or instructs another to directly infringe a patent knowing that the encouraged activity infringes, and contributory infringement, where a party sells or offers to sell a component that has no substantial non-infringing use and that is a material part of a patented combination or process. Indirect infringement requires an underlying act of direct infringement and is commonly at issue in cases involving component manufacturers, software distributors, and platform companies.
Litigation in Federal Court
Patent infringement claims are exclusively within the jurisdiction of the federal courts. Most patent cases are filed in district courts, and certain courts — particularly the District of Delaware, the Eastern District of Texas, and the Western District of Texas — handle a disproportionately large share of patent litigation due to their patent-friendly procedural rules, experienced judges, and established caselaw. Appeals from district court patent decisions go to the Court of Appeals for the Federal Circuit, a specialized appellate court with exclusive jurisdiction over patent appeals, which ensures national uniformity in patent law.
Patent litigation is among the most expensive categories of US commercial litigation. The American Intellectual Property Law Association surveys routinely indicate that the median cost of litigating a patent case through trial, where more than $25 million is at risk, can exceed $5 million per side. Even smaller cases can cost well over $1 million. These economics have driven the development of alternative resolution strategies — including inter partes review at the PTAB, discussed below — as well as a significant market for third-party litigation funding and, on the other side, for insurance products covering patent defense costs.
Remedies for Infringement
A successful patent plaintiff may obtain injunctive relief, monetary damages, and, in exceptional cases, enhanced damages and attorney’s fees. Following the Supreme Court’s decision in eBay Inc. v. MercExchange, L.L.C. (2006), permanent injunctions are no longer automatic in patent cases; courts must apply traditional equitable principles and balance the hardship to the parties and the public interest. In practice, injunctions are regularly granted where the patent owner and infringer are direct competitors, but are less routinely available to non-practicing entities — commonly called patent assertion entities or “patent trolls” — that do not themselves practice the patented technology.
Monetary damages must be “adequate to compensate for the infringement, but in no event less than a reasonable royalty for the use made of the invention by the infringer” (35 U.S.C. § 284). Damages may be measured as lost profits (if the patent owner can establish that it would have made the infringer’s sales but for the infringement) or as a reasonable royalty (the hypothetical royalty that would have been negotiated between a willing licensor and licensee at the time infringement began). Reasonable royalty analysis is the more common damages methodology and involves a multi-factor analysis often called the Georgia-Pacific factors, based on a 1970 district court decision that set out fifteen factors relevant to royalty rate determination.
PTAB Post-Grant Proceedings
The Patent Trial and Appeal Board (PTAB), created by the AIA, hears two primary types of post-grant challenges to patent validity: inter partes review (IPR) and post-grant review (PGR). An IPR can be filed by any party that is not the patent owner, at any time after the patent has been in force for nine months, challenging issued claims based on prior art patents and printed publications. A PGR must be filed within nine months of patent grant and can challenge validity on any ground. These proceedings have become an important tool for businesses facing patent infringement assertions — they offer a faster, less expensive alternative to challenging patent validity in district court, with a more patent-skeptical standard of review.
The PTAB has been controversial because its institution rates and invalidation rates have been perceived by patent owners as systematically unfavorable. The Supreme Court’s decision in United States v. Arthrex, Inc. (2021) addressed constitutional concerns about the appointment of PTAB judges, and the current Director of the USPTO has implemented Director Review procedures that provide an additional layer of oversight of PTAB decisions. For businesses accused of infringement, an IPR petition filed promptly after receipt of an infringement complaint is a standard defensive tactic that should be evaluated in virtually every patent litigation scenario.
Key Trends and Developments for Business
Patent Eligibility Reform
The uncertainty created by the Alice/Mayo framework has generated significant debate in Congress, the courts, and the patent community about the need for statutory reform of Section 101. Multiple legislative proposals have been introduced in recent sessions of Congress to clarify patent eligibility standards, particularly for software and life sciences inventions, though as of this writing no comprehensive reform has been enacted. Businesses — particularly in software, biotechnology, and medical diagnostics — should monitor this legislative landscape closely, as changes to Section 101 could significantly affect both the ability to obtain new patents and the vulnerability of existing ones.
Standard Essential Patents and FRAND Licensing
In industries where products must comply with technical standards — wireless telecommunications (4G/5G), Wi-Fi, Bluetooth, video codecs — patents that cover technology incorporated into the standard are called standard essential patents (SEPs). Owners of SEPs who participate in standard-setting organizations typically commit to licensing those patents on fair, reasonable, and non-discriminatory (FRAND) terms. The terms of FRAND licenses, and the enforcement of FRAND commitments, have been the subject of extensive litigation in the US and internationally. Businesses in telecommunications, consumer electronics, and connected devices that either hold SEPs or that manufacture standards-compliant products should be familiar with FRAND obligations and the complex licensing disputes they generate.
Patent Assertion Entities
Patent assertion entities (PAEs) — companies whose primary business is acquiring patents and asserting them against operating companies — remain a significant feature of the US patent landscape. PAEs often send demand letters to businesses asserting that their products or services infringe patents and demanding licensing fees. Businesses that receive such demands should resist the temptation to pay small settlement amounts without evaluating the merits of the claims; such payments can create records of acknowledgment of the patent’s validity that complicate later challenges. Consulting experienced patent litigation counsel at the first receipt of a patent demand letter is strongly advisable.
Conclusion
The US patent system offers businesses a powerful framework for protecting innovation, creating competitive advantage, and generating value from research and development investment. But it is also a complex, costly, and actively litigated system in which the rights available depend critically on the decisions made at every stage — from the initial assessment of whether and what to patent, through the drafting and prosecution of applications, to the enforcement or defense of patent rights in litigation. Mistakes made early in the process — failing to file before a public disclosure, failing to require invention assignment agreements from employees, drafting overly narrow or overly broad claims, neglecting maintenance fee deadlines — can permanently foreclose opportunities that would otherwise have been available.
For most businesses, a sound patent strategy begins with engaging qualified patent counsel — attorneys registered to practice before the USPTO who combine technical expertise with legal skill — early and maintaining an ongoing dialogue about the company’s innovation pipeline. Patent protection is not a one-time event; it is a program that must evolve with the business, the technology, and the competitive landscape. Businesses that treat patents as an afterthought or as a cost center rather than a strategic asset will invariably find themselves at a disadvantage compared to competitors who understand and actively manage their intellectual property.
Whether you are a startup seeking to build a defensive patent portfolio, an established company managing a large portfolio across multiple technology areas, a manufacturer conducting freedom-to-operate analysis before a product launch, or a business responding to a patent assertion, understanding the fundamentals of US patent law is an essential element of sound commercial and legal strategy. We encourage you to consult with qualified patent counsel to assess your specific situation and to develop an approach suited to your business objectives, technical capabilities, and competitive environment.
This article is provided for general informational and educational purposes only and does not constitute legal advice.
Reading this article does not create an attorney-client relationship. Please consult a qualified attorney regarding your specific legal situation.